The chronic and progressive inflammatory disease bronchiectasis is characterised by permanent bronchi dilation and by ...

Report on how AI is redefining market landscape - The Global Gastrointestinal Diseases Therapeutics Market size is es ...

Pediatric Orphan Drug Market is Segmented by Type (Oncology, Pulmonary, Neurology, Hematology, Endocrinology, Cardio-vascular, Metabolic Disorders), by Application (0-1 Years, 1-3 Years, 3-6 Years, ...

Tracking patient response to DMARD therapy has the potential to improve remission, but multiple barriers must be overcome ...

Boehringer Ingelheim had previously explored Ofev as a treatment ... The trial was redesigned with a new endpoint and the ...

The study authors acknowledged the small sample in their study ... Axon Therapies, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Cyclerion, Cytokinetics, Edwards ...

suggested that HU6's null results for most secondary endpoints may be a consequence of the present study's small sample and relatively short duration. She remarked on the "modest" extent of body ...

Boehringer Ingelheim announces 2024 GRANTS recipients Recipients ... PRRSV recombination and PRRSV mixed infection (>2 PRRSV strains) in diagnostic samples), and Suzanne Leonard (Smart sensing for ...